Custom service

Biotinylated pMHC Monomer Production

Produce biotinylated peptide–mhc monomers as the raw material for tetramers

Turnaround: 4–6 weeksTypical scale: 50 µg – 1 mg tetramer per constructChemistry options: BirA-acceptor-peptide construct design; in-vitro biotinylation; SEC polishing of monomer

The service is built around BirA-acceptor-peptide construct design. Depending on the molecule we may move to in-vitro biotinylation or SEC polishing of monomer to improve stability, loading or yield, and every batch is released with biotinylated pMHC monomer with biotinylation ratio.

Because Biotinylated pMHC Monomer Production projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.

Downstream tetramer and dextramer assembly

SPR and BLI binding studies

Monomers without a defined target peptide

Alleles or peptides with no published refolding precedent and no feasibility budget

Each tetramer lot is tested functionally, not just biochemically: a known antigen-specific T cell line or clone is stained, and the lot is released only if the staining profile meets the agreed specification. Allele and peptide identity are confirmed by MS.

Service Highlights

  • BirA-acceptor-peptide construct design as the default route, with in-vitro biotinylation held as a proven fallback
  • SEC polishing of monomer worked into the design where the application requires it
  • Refolding yield and monomer integrity confirmed by SEC before tetramerization
  • Analytical confirmation of every intermediate before the final release
  • Fluorescent labels chosen and titrated so staining signal stays in the linear range
  • Biotinylated pMHC monomer with biotinylation ratio delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Construct design

    Allele, peptide and biotinylation acceptor peptide are confirmed, and the expression construct strategy is agreed.

  2. Inclusion body preparation

    Heavy chain and β2-microglobulin are expressed and purified as inclusion bodies.

  3. Refolding

    Chain, β2M and peptide are folded together under redox-buffered conditions optimized for the allele.

  4. Biotinylation & purification

    Monomer is BirA-biotinylated and polished by SEC-HPLC to remove aggregates.

  5. Tetramerization

    Fluorescent streptavidin is titrated in to form stable tetramers with controlled label ratio.

  6. Functional release

    Biotinylated pMHC monomer with biotinylation ratio is released after flow-cytometry binding confirmation against the specification.

Specifications & timeline

Turnaround
4–6 weeks
Typical scale
50 µg – 1 mg tetramer per construct
Chemistry options
BirA-acceptor-peptide construct design; in-vitro biotinylation; SEC polishing of monomer
Deliverable
Biotinylated pMHC monomer with biotinylation ratio
QC package
SEC-HPLC monomer integrity, biotinylation ratio, flow-cytometry binding test
Shipping
Dry ice, aliquoted to avoid freeze-thaw

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.